<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01379053</url>
  </required_header>
  <id_info>
    <org_study_id>MRSA1</org_study_id>
    <nct_id>NCT01379053</nct_id>
  </id_info>
  <brief_title>Volatile Organic Compounds in Staphylococcus Aureus Patients</brief_title>
  <acronym>MRSAVOC</acronym>
  <official_title>Detection of Methicillin Resistant Staphylococcus Aureus Colonization Using the zNose速, an Ultra-fast Gas Chromatograph</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Landon Pediatric Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Landon Pediatric Foundation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The zNose速 MRSA test is a non-invasive breath test for markers of Staphylococcus aureus,&#xD;
      which may predict the probability of bacterial organisms in the anterior nares, throat and&#xD;
      respiratory tract, wounds, and anus and therefore be able to replace or supplement current&#xD;
      active Methicillin Resistant Staphylococcus Aureus (MRSA) surveillance efforts. It consists&#xD;
      of:&#xD;
&#xD;
        -  A collection apparatus for collection of volatile compounds from suspected infection&#xD;
           sites onto a sorbent trap or Tedlar bag, as well as for the collection of a separate&#xD;
           sample of room air.&#xD;
&#xD;
        -  Analysis of the volatile organic compounds from suspected infection sites and room air&#xD;
           by short acoustic wave gas chromatography.&#xD;
&#xD;
        -  Interpretation of the volatile organic compounds with a proprietary algorithm in order&#xD;
           to predict the probability of Staphylococcus aureus infection and colonization.&#xD;
&#xD;
      This study will test the hypothesis that we can identify the presence of MRSA by sampling the&#xD;
      &quot;head space&quot; above culture media of anterior nare samples provided by patients with MRSA.&#xD;
      Additionally, this study will test the hypothesis that we can identify the presence of MRSA&#xD;
      by sampling air exhaled through the nostrils (nasal exhalant).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identification of Methicillin Resistant Staphyloccus aureus</measure>
    <time_frame>one week</time_frame>
    <description>Identification during clinic visit of MRSA</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">10</enrollment>
  <condition>Staphylococcus Aureus</condition>
  <condition>Methicillin-resistant Staphylococcus Aureus</condition>
  <condition>Nosocomial Disease</condition>
  <arm_group>
    <arm_group_label>Staphylococcus Patients</arm_group_label>
    <description>Patients suspected of having Methicillin-resistant and/or methicillin-susceptible staphylococcus aureus.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Healthy volunteer</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be selected upon suspicion of MRSA or MSSA infection or colonization.&#xD;
        Increased concentration will be give to selection of persons from the following high risk&#xD;
        groups:&#xD;
&#xD;
          -  It has been documented that the patient has been previously discharged from a general&#xD;
             acute care hospital within 30 days prior to the current hospital admission.&#xD;
&#xD;
          -  The patient will be admitted to an intensive care unit or burn unit of the hospital.&#xD;
&#xD;
          -  The patient receives inpatient dialysis treatment.&#xD;
&#xD;
          -  The patient is being transferred from a skilled nursing facility&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Suspicion of staphylococcus aureus infection or colonization&#xD;
&#xD;
          -  Able to give samples for zNose速 analysis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to provide sample for zNose速 analysis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ventura County Medical Center Hospital</name>
      <address>
        <city>Ventura</city>
        <state>California</state>
        <zip>93003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <study_first_submitted>June 21, 2011</study_first_submitted>
  <study_first_submitted_qc>June 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 23, 2011</study_first_posted>
  <last_update_submitted>August 12, 2014</last_update_submitted>
  <last_update_submitted_qc>August 12, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 13, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Landon Pediatric Foundation</investigator_affiliation>
    <investigator_full_name>Chris Landon</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Staphylococcus aureus</keyword>
  <keyword>Methicillin-resistant staphylococcus aureus</keyword>
  <keyword>Nosocomial disease</keyword>
  <keyword>Electronic nose</keyword>
  <keyword>Gas chromatography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Staphylococcal Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

